A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma

Status:
Completed

Trial end date:
2009-05-01

Target enrollment:

Participant gender:

This is a phase one study to evaluate the safety, tolerability, and bioavailability of nebulized AIR645.

Phase 1

Altair Therapeutics, Inc.

Pharmaceutical Solutions